Table 1.

Distribution of HM-PRO Scores and P-Values^* by Disease Type and Sociodemographic Characteristics

Factor	n	Part A		Part B
		Median [IQR]	P	Median [IQR]	P
Leukemia type			0.55		0.23
Acute lymphoblastic	139	33.1 [17.2, 52.5]		26.5 [11.8, 44.1]
Acute myeloid	332	30.4 [16.0, 50.5]		20.6 [11.8, 38.2]
Acute promyelocytic	81	29.2 [7.3, 51.7]		23.5 [14.7, 41.2]
Gender			0.06		0.002
Male	222	29.3 [12.7, 49.5]		17.6 [8.8, 35.3]
Female	327	31.4 [18.2, 53.0]		23.5 [14.7, 44.1]
Missing	3	9.4 [0.0, 27.4]		20.6 [2.9, 23.5]
Age in years			0.005		0.03
16–40	158	35.9 [20.5, 56.9]		23.5 [11.8, 47.1]
41–60	240	31.3 [16.9, 51.6]		23.5 [11.8, 41.2]
61–87	150	26.5 [11.7, 45.8]		17.6 [8.8, 32.4]
Missing	4	43.6 [31.3, 47.5]		35.3 [29.4, 39.7]
Income			<0.001		<0.001
Low	136	42.0 [25.0, 63.0]		29.4 [17.6, 48.5]
Average	281	28.8 [16.1, 47.4]		20.6 [8.8, 38.2]
High	67	22.4 [8.5, 41.7]		14.7 [2.9, 32.4]
Not answered	68	29.0 [14.4, 49.7]		26.5 [11.8, 44.1]
World Health Organization region			0.04		0.17
Europe	380	30.0 [14.5, 50.4]		20.6 [8.8, 39.7]
Not Europe	163	33.3 [21.0, 53.7]		23.5 [11.8, 44.1]
Not answered	9	25.8 [21.2, 31.0]		23.5 [11.8, 29.4]

^*P-values for differences were obtained using Wilcoxon rank-sum test, Kruskal Wallis rank-sum test, or nonparametric trend test. Missing responses were not included in these tests.

HM-PRO; hematological malignancy-specific patient-reported outcome measure; IQR, interquartile range.